Patents by Inventor Ernest S. Hamanaka

Ernest S. Hamanaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4772597
    Abstract: Certain 2-azacycloalkylthio-2-penem-3-carboxylic acid compounds are useful as antibacterials for treating mammals and have the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein: R is ##STR2## A is alkylene having 2-4 carbon atoms, alkylene having 2-4 carbon atoms wherein a carbon atom has an oxo substituent or alkylene having 2-4 carbon atoms wherein a methylene is replaced by oxygen, S(O).sub.m, or N--R.sub.3 ;B is carbonyl, thiocarbonyl, methylene or imine;R.sub.1 is hydrogen or forms an ester group which is hydroyzed in vivo;R.sub.2 is hydrogen, formyl, alkylcarbonyl, N-alkylaminocarbonyl, N-alkylaminosulfonyl, aminosulfonyl, aminocarbonyl, alkoxycarbonyl having 2-5 carbon atoms, alkylsulfonyl, alkyl, or alkyl substituted by aminocarbonyl, alkyl--S(O).sub.m --, hydroxyl, amino, alkylcarbonylamino, formamido or alkylsulfonylamino, wherein each alkyl has 1-4 carbon atoms;R.sub.
    Type: Grant
    Filed: September 13, 1984
    Date of Patent: September 20, 1988
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4725678
    Abstract: Certain 2-substituted-2-penem-3-carboxylic acid compounds and pharmaceutically-acceptable salts thereof can be prepared from the appropriate xanthate or trithiocarbonate by desulfurization and addition of an electrophilic sulfur compound followed by halogenation and ring closure. The corresponding desulfurized and halogenated olefinic intermediates are disclosed.
    Type: Grant
    Filed: April 4, 1986
    Date of Patent: February 16, 1988
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4619783
    Abstract: Certain substituted-2-penem-3-carboxylic acid compounds, and pharmaceutically-acceptable salts thereof, can be prepared from the appropriate xanthate or trithiocarbonate by desulfurization, followed by halogenation and ring closure. The corresponding desulfurized and halogenated intermediates are disclosed.
    Type: Grant
    Filed: June 10, 1983
    Date of Patent: October 28, 1986
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4619924
    Abstract: Certain 2-alkylthio-2-penem-3-carboxylic acid compounds are useful as antibacterials for treating mammals.
    Type: Grant
    Filed: November 27, 1984
    Date of Patent: October 28, 1986
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4614737
    Abstract: Certain 2-dioxacycloalkylthio-2-penem-3-carboxylic acid compounds are useful as antibacterials for treating mammals and have the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein: R is ##STR2## A is carbonyl, methylene or thiocarbonyl; B is alkylene having 2-5 carbon atoms;alk is alkylene having 1-6 carbon atoms;R.sub.1 is hydrogen or a group which results in an ester which is hydrolyzable in vivo; andn is zero or one.
    Type: Grant
    Filed: September 13, 1984
    Date of Patent: September 30, 1986
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4595539
    Abstract: Certain 2-substituted-2-penem-3-carboxylic acid compounds and pharmaceutically-acceptable salts thereof can be prepared from the appropriate xanthate or trithiocarbonate by desulfurization and addition of an electrophilic sulfur compound followed by halogenation and ring closure. The corresponding desulfurized and halogenated olefinic intermediates are disclosed.
    Type: Grant
    Filed: June 10, 1983
    Date of Patent: June 17, 1986
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4521533
    Abstract: Salts of readily hydrolyzable esters of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide and (a) prodrug forms of ampicillin and amoxicillin or (b) ampicillin and amoxicillin and a dibasic acid are readily absorbed following oral adminstration, and are useful in treating bacterial infections.
    Type: Grant
    Filed: July 12, 1984
    Date of Patent: June 4, 1985
    Assignee: Pfizer Inc.
    Inventors: Ernest S. Hamanaka, John G. Stam
  • Patent number: 4486411
    Abstract: 6-Beta-sulfonyloxypenicillanic acid derivatives are novel beta-lactamase inhibitors, useful in combination with standard beta-lactam antibiotics against bacterial strains otherwise resistant to said beta-lactam antibiotics by dint of their production of beta-lactamases.
    Type: Grant
    Filed: July 1, 1981
    Date of Patent: December 4, 1984
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4397783
    Abstract: 6-.beta.-Substituted penicillanic acids and derivatives thereof as useful enhancers of the effectiveness of several .beta.-lactam antibiotics against many .beta.-lactamase producing bacteria, and 6-.beta.-substituted penicillanic acid derivatives wherein the carboxy group is protected by a conventional penicillin carboxy protecting group as useful intermediates leading to said synergistic agents. A process for converting 6,6-disubstituted penicillanic acid derivatives to the corresponding 6-.beta.-substituted penicillanic acid congeners.
    Type: Grant
    Filed: November 23, 1979
    Date of Patent: August 9, 1983
    Assignee: Pfizer Inc.
    Inventors: Michael S. Kellogg, Ernest S. Hamanaka
  • Patent number: 4359472
    Abstract: Antibacterial agents in which a penicillin and a beta-lactamase inhibitor are linked by means of a bis-hydroxymethyl carbonate bridge are of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein R.sup.1 is hydrogen, hydroxy, certain acyloxy or certain alkoxycarbonyloxy groups, a method for their use, pharmaceutical compositions thereof, and intermediates useful in their production.
    Type: Grant
    Filed: December 22, 1981
    Date of Patent: November 16, 1982
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 4073783
    Abstract: 6- .alpha.-(Amidino- and imidoylaminoalkanoylamino)aracylamino!-penicillanic acids and synthetic methods for the preparation thereof.
    Type: Grant
    Filed: December 15, 1975
    Date of Patent: February 14, 1978
    Assignee: Pfizer Inc.
    Inventors: Ernest S. Hamanaka, John G. Stam
  • Patent number: 4025506
    Abstract: 6-[.alpha.-(Amidino- and imidoylaminoalkanoylamino)aracylamino]-penicillanic acids and synthetic methods for the preparation thereof.
    Type: Grant
    Filed: December 15, 1975
    Date of Patent: May 24, 1977
    Assignee: Pfizer Inc.
    Inventors: Ernest S. Hamanaka, John G. Stam
  • Patent number: 4025504
    Abstract: 6-[.alpha.-(Amidino- and imidoylaminoalkanoylamino)aracylamino]-penicillanic acids and synthetic methods for the preparation thereof.
    Type: Grant
    Filed: December 15, 1975
    Date of Patent: May 24, 1977
    Assignee: Pfizer Inc.
    Inventors: Ernest S. Hamanaka, John G. Stam
  • Patent number: 3972872
    Abstract: 6-[.alpha.-(.omega.-GUANIDINOALKANOYLAMIDO)ACYLAMIDO]PENICILLANIC ACIDS, THE NON-TOXIC SALTS AND ESTERS THEREOF ARE USEFUL AS ANTIBACTERIAL AGENTS, THERAPEUTIC AGENTS IN ANIMALS, INCLUDING MAN, OF PARTICULAR VALUE AGAINST GRAM-NEGATIVE BACTERIA, AND AS ANIMAL FEED NUTRITIONAL SUPPLEMENTS.
    Type: Grant
    Filed: May 6, 1975
    Date of Patent: August 3, 1976
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka
  • Patent number: 3951952
    Abstract: 6-[.alpha.-(Amidino- and imidoylaminoalkanoylamino)aracylamino]-penicillanic acids and synthetic methods for the preparation thereof.
    Type: Grant
    Filed: December 14, 1973
    Date of Patent: April 20, 1976
    Assignee: Pfizer Inc.
    Inventors: Ernest S. Hamanaka, John G. Stam
  • Patent number: 3933797
    Abstract: 6-[.alpha.-(.omega.-GUANIDINOALKANOYLAMIDO)ACYLAMIDO]PENICILLANIC ACIDS, THE NON-TOXIC SALTS AND ESTERS THEREOF ARE USEFUL AS ANTIBACTERIAL AGENTS, THERAPEUTIC AGENTS IN ANIMALS, INCLUDING MAN, OF PARTICULAR VALUE AGAINST GRAM-NEGATIVE BACTERIA, AND AS ANIMAL FEED NUTRITIONAL SUPPLEMENTS.
    Type: Grant
    Filed: September 23, 1974
    Date of Patent: January 20, 1976
    Assignee: Pfizer Inc.
    Inventor: Ernest S. Hamanaka